Skip to main content
. Author manuscript; available in PMC: 2024 Aug 18.
Published in final edited form as: J Neurol Neurosurg Psychiatry. 2024 Aug 16;95(9):812–821. doi: 10.1136/jnnp-2023-332862

Figure 5. Clinical variant predictions according to FDG-PET hypometabolism, stratified by neuropathology.

Figure 5.

A subset of 45 patients who underwent FDG-PET are presented on the 3D model; Color and shape are representative of neuropathology primary diagnosis. X, Y, Z axes are odds-ratio representative of the likelihood of specific pathology according to FDG-PET. Linear discriminant analysis is shown in the upper right corner.

Tau: primary neuropathology diagnosis of 4R- or 3R- tauopathy.

SV: StateViewer. AD: Alzheimer’s Disease; LBD: Lewy body disease; FTLD-TDP43: Frontotemporal lobar degeneration-TAR DNA-binding protein 43.